DBV Technologies (DBVT) Receivables (2015 - 2023)
DBV Technologies (DBVT) posted Receivables of $1.4 million for Q4 2023, down 10.04% sequentially from $1.5 million in Q4 2022, and down 10.04% YoY from $1.5 million in Q4 2022.
DBV Technologies (DBVT) Receivables (2015 - 2023) Analysis & Trends
DBV Technologies has reported Receivables for 7 years, with the latest figure at $1.4 million in Q4 2023.
- Quarterly Receivables fell 10.04% year-over-year to $1.4 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $1.4 million (down 10.04% YoY) and the FY2023 annual result came in at $1.4 million, down 10.04% from the prior year.
- Receivables fell to $1.4 million in Q4 2023 per DBVT's latest filing, from $1.5 million in the prior quarter.
- Over five years, Receivables peaked at $2.8 million in Q4 2020 and troughed at $1.3 million in Q4 2021.
- A 4-year average of $1.7 million and a median of $1.4 million in 2022 frame the typical range for Receivables.
- The sharpest annual moves came in 2021 and 2022: Receivables tumbled 54.39% in 2021, then rose 17.32% in 2022.
- Over 4 years, Receivables stood at $2.8 million in 2020, then sank by 54.39% to $1.3 million in 2021, then gained by 17.32% to $1.5 million in 2022, then dropped by 10.04% to $1.4 million in 2023.
- According to Business Quant data, Receivables over the past three periods registered $1.4 million, $1.5 million, and $1.3 million for Q4 2023, Q4 2022, and Q4 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.93 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.06 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1.84 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 912.74 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 215.33 Mn |
| 10 | DBV Technologies | 6.08 Bn | 5.90 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.35 Mn |
| Dec 31, 2022 | 1.50 Mn |
| Dec 31, 2021 | 1.28 Mn |
| Dec 31, 2020 | 2.81 Mn |
| Dec 31, 2017 | 2.89 Mn |
| Dec 31, 2016 | 3.40 Mn |
| Dec 31, 2015 | 1.56 Mn |